Search research articles
Contact Us
Filters
Showing results (151-160 of 166) with videos related to
Page
of 17
Sort By:
Pharmaceutics
|
August 23, 2020
Influence of Probenecid on the Pharmacokinetics and Pharmacodynamics of Sorafenib
Koen G A M Hussaarts, Leni van Doorn, Karel Eechoute, et al.
Nature Genetics
|
January 11, 2024
A new genomic framework to categorize pediatric acute myeloid leukemia
Masayuki Umeda, Jing Ma, Tamara Westover, et al.
Nature Communications
|
June 1, 2023
Increased renal elimination of endogenous and synthetic pyrimidine nucleosides in concentrative nucleoside transporter 1 deficient mice
Avinash K Persaud, Matthew C Bernier, Michael A Massey, et al.
JCI Insight
|
December 3, 2020
TP-0903 is active in models of drug-resistant acute myeloid leukemia
Jae Yoon Jeon, Daelynn R Buelow, Dominique A Garrison, et al.
Nature Communications
|
March 17, 2016
A phosphotyrosine switch regulates organic cation transporters
Jason A Sprowl, Su Sien Ong, Alice A Gibson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 20, 2012
Influence of polymorphic OATP1B-type carriers on the disposition of docetaxel
Anne-Joy M de Graan, Cynthia S Lancaster, Amanda Obaidat, et al.
JCI Insight
|
June 22, 2023
Targeting a xenobiotic transporter to ameliorate vincristine-induced sensory neuropathy
Yang Li, Thomas Drabison, Mahesh Nepal, et al.
Nature Communications
|
April 23, 2020
A kinome-wide screen identifies a CDKL5-SOX9 regulatory axis in epithelial cell death and kidney injury
Ji Young Kim, Yuntao Bai, Laura A Jayne, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 23, 2023
<i>DPYD</i> Testing: Time to Put Patient Safety First
Sharyn D Baker, Susan E Bates, Gabriel A Brooks, et al.
Cancer Research Communications
|
June 25, 2025
A Phase 1b/2 Study of TP-0903 and Decitabine Targeting Mutant TP53 and/or Complex Karyotype in Patients with Untreated Acute Myeloid Leukemia ≥Age 60 Years
Eric D Eisenmann, Ronan Swords, Ying Huang, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 166) with videos related to
Sort By:
Page
of 17
Pharmaceutics
|
August 23, 2020
Influence of Probenecid on the Pharmacokinetics and Pharmacodynamics of Sorafenib
Koen G A M Hussaarts, Leni van Doorn, Karel Eechoute, et al.
Nature Genetics
|
January 11, 2024
A new genomic framework to categorize pediatric acute myeloid leukemia
Masayuki Umeda, Jing Ma, Tamara Westover, et al.
Nature Communications
|
June 1, 2023
Increased renal elimination of endogenous and synthetic pyrimidine nucleosides in concentrative nucleoside transporter 1 deficient mice
Avinash K Persaud, Matthew C Bernier, Michael A Massey, et al.
JCI Insight
|
December 3, 2020
TP-0903 is active in models of drug-resistant acute myeloid leukemia
Jae Yoon Jeon, Daelynn R Buelow, Dominique A Garrison, et al.
Nature Communications
|
March 17, 2016
A phosphotyrosine switch regulates organic cation transporters
Jason A Sprowl, Su Sien Ong, Alice A Gibson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 20, 2012
Influence of polymorphic OATP1B-type carriers on the disposition of docetaxel
Anne-Joy M de Graan, Cynthia S Lancaster, Amanda Obaidat, et al.
JCI Insight
|
June 22, 2023
Targeting a xenobiotic transporter to ameliorate vincristine-induced sensory neuropathy
Yang Li, Thomas Drabison, Mahesh Nepal, et al.
Nature Communications
|
April 23, 2020
A kinome-wide screen identifies a CDKL5-SOX9 regulatory axis in epithelial cell death and kidney injury
Ji Young Kim, Yuntao Bai, Laura A Jayne, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 23, 2023
<i>DPYD</i> Testing: Time to Put Patient Safety First
Sharyn D Baker, Susan E Bates, Gabriel A Brooks, et al.
Cancer Research Communications
|
June 25, 2025
A Phase 1b/2 Study of TP-0903 and Decitabine Targeting Mutant TP53 and/or Complex Karyotype in Patients with Untreated Acute Myeloid Leukemia ≥Age 60 Years
Eric D Eisenmann, Ronan Swords, Ying Huang, et al.
Page
of 17